Type 2 diabetes trials in Kazakhstan

4 of 7 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  iCaReMe Global Registry: Multinational Real-world Evidence in Cardiorenal and Metabolic Diseases

  Where

  Aktobe, Almaty

  Age

  18 years and over

  People

  35,000 worldwide

  Run by

  AstraZeneca

  See details and how to joinNCT03549754
• No phaseTaking people
  Assessment of Pancreatic Dysfunction in Patients With Type 2 Diabetes

  Where

  Aktobe

  Age

  18 years to 74 years

  People

  310

  Run by

  West Kazakhstan Marat Ospanov Medical University

  See details and how to joinNCT07512934
• No phaseTaking people
  Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

  Where

  Almaty

  Age

  18 years to 69 years

  People

  6,720

  Run by

  Asfendiyarov Kazakh National Medical University

  See details and how to joinNCT06953180
• No phaseEnrolling by invitation
  Study of Genome-associated Mechanisms of Diabetic Nephropathy and Evaluation of Nephroprotective Therapy in Patients With Type 2 Diabetes Mellitus in the Kazakh Population

  Where

  Astana

  Age

  18 years to 65 years

  People

  100

  Run by

  Astana Medical University

  See details and how to joinNCT07038213